AMAG Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

LEXINGTON, Mass.–(BUSINESS WIRE)–Nov. 7, 2012–
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Frank
Thomas, AMAG’s Chief Operating Officer, will present a company overview
and business update at the Lazard Capital Markets 9^th Annual
Healthcare Conference on Tuesday, November 13, 2012 at 8:00 am ET in New
York, NY.

A live webcast of the presentation will be accessible through the
Investors section of the company’s website at www.amagpharma.com.
Following the conference, the webcast will be archived on the AMAG
Pharmaceuticals, Inc. website until December 13, 2012.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company focused
on the development and commercialization of a therapeutic iron compound
to treat iron deficiency anemia. For additional company information,
please visit www.amagpharma.com.

Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303